Edward H. Ruediger

783 citations

26 papers · 383 indexed · h-index 13

Co-authors: Edward Piers Alain Martel Nicholas A. Meanwell Sham S. Gandhi Martin S. Gibson Makonen Belema Dolatrai M. Vyas David W. Smith
Topics: Bioactive Compounds and Antitumor Agents (4 papers)HIV/AIDS drug development and treatment (4 papers)HIV Research and Treatment (3 papers)
Cited by: Organic Chemistry Hepatology Toxicology
Journals: Journal of Molecular Biology Journal of Medicinal Chemistry Journal of Pharmacology and Experimental Therapeutics
Partner nations: United States Canada Germany

In The Last Decade

Edward H. Ruediger

25 papers receiving 372 citations

Peers

Countries citing papers authored by Edward H. Ruediger

Since Specialization

Citations

This map shows the geographic impact of Edward H. Ruediger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Edward H. Ruediger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Edward H. Ruediger more than expected).

Fields of papers citing papers by Edward H. Ruediger

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Edward H. Ruediger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Edward H. Ruediger. The network helps show where Edward H. Ruediger may publish in the future.

Co-authorship network of co-authors of Edward H. Ruediger

This figure shows the co-authorship network connecting the top 25 collaborators of Edward H. Ruediger. A scholar is included among the top collaborators of Edward H. Ruediger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Edward H. Ruediger. Edward H. Ruediger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Medicinal Chemistry and NMR Driven Discovery of Novel UDP-glucuronosyltransferase 1A Inhibitors That Overcome Therapeutic Resistance in Cells 2023 ·Journal of Molecular Biology ·Michael J. Osborne,(unknown),Biljana Culjkovic‐Kraljacic,(unknown),Edward H. Ruediger,(unknown),Anne Marinier,Sarit Assouline,Katherine L. B. Borden	3
2	Dual-Target Inhibitors of the Folate Pathway Inhibit Intrinsically Trimethoprim-Resistant DfrB Dihydrofolate Reductases 2020 ·ACS Medicinal Chemistry Letters ·(unknown),Genbin Shi,(unknown),Maximilian C. C. J. C. Ebert,(unknown),Marc Gagnon,Edward H. Ruediger,(unknown),Delphine Forge,Jean Jacques Vanden Eynde,Anne Marinier,Xinhua Ji,Joelle N. Pelletier	11
3	Structure-Based Design of Dimeric Bisbenzimidazole Inhibitors to an Emergent Trimethoprim-Resistant Type II Dihydrofolate Reductase Guides the Design of Monomeric Analogues 2019 ·ACS Omega ·(unknown),Brahm J. Yachnin,Edward H. Ruediger,(unknown),Marc Gagnon,(unknown),Maximilian C. C. J. C. Ebert,Delphine Forge,Dominic Bastien,(unknown),Jean Jacques Vanden Eynde,Anne Marinier,Albert M. Berghuis,Joelle N. Pelletier	8
4	The effects of NS5A inhibitors on NS5A phosphorylation, polyprotein processing and localization 2011 ·Journal of General Virology ·Dike Qiu,Julie A. Lemm,Donald R. O’Boyle,Jin-Hua Sun,Peter T. Nower,(unknown),Lawrence G. Hamann,Lawrence B. Snyder,(unknown),Edward H. Ruediger,Nicholas A. Meanwell,Makonen Belema,Min Gao,Robert A. Fridell	44
5	Synthesis and biological evaluation of 4-amino derivatives of benzimidazoquinoxaline, benzimidazoquinoline, and benzopyrazoloquinazoline as potent IKK inhibitors 2006 ·Bioorganic & Medicinal Chemistry Letters ·Françis Beaulieu,Carl Ouellet,Edward H. Ruediger,Makonen Belema,Yuping Qiu,Xuejie Yang,Jacques Banville,James R. Burke,Kurt R. Gregor,John F. MacMaster,Alain Martel,Kim W. McIntyre,Mark A. Pattoli,F. Christopher Zusi,Dolatrai M. Vyas	45
6	General Synthesis of Tetrasubstituted Alkenyl‐1,3,4‐oxadiazoles. 2006 ·ChemInform ·Clint A. James,Brigitte Poirier,(unknown),Alain Martel,Edward H. Ruediger	1
7	Novel 3‘,6‘-Anhydro and N12,N13-Bridged Glycosylated Fluoroindolo[2,3-a]carbazoles as Topoisomerase I Inhibitors. Fluorine as a Leaving Group from sp³Carbon 2005 ·Organic Letters ·Mark G. Saulnier,David R. Langley,David B. Frennesson,Byron H. Long,Stella Huang,Qi Gao,Dedong Wu,Craig R. Fairchild,Edward H. Ruediger,Kurt Zimmermann,Denis R. St. Laurent,Balu Balasubramanian,Dolatrai M. Vyas	17
8	Novel 3′‐Deoxy Analogues of the anti‐HBV Agent Entecavir: Synthesis of Enantiomers from a Single Chiral Epoxide. 2004 ·ChemInform ·Edward H. Ruediger,Alain Martel,Nicholas A. Meanwell,(unknown),(unknown)	2
9	β-Alanine dipeptides as MC4R agonists 2003 ·Bioorganic & Medicinal Chemistry Letters ·Réjean Ruel,Timothy F. Herpin,Lawrence G. Iben,Guanglin Luo,Alain Martel,Helen S. Mason,Gail K. Mattson,Brigitte Poirier,Edward H. Ruediger,Dan Shi,(unknown),Guixue Yu,I Zimányi,Graham S. Poindexter,John E. Macor	17
10	2-Arylaminothiazoles as high-affinity corticotropin-Releasing factor 1 receptor (CRF1R) antagonists: synthesis, binding studies and behavioral efficacy 2003 ·Bioorganic & Medicinal Chemistry Letters ·Gene M. Dubowchik,(unknown),Dmitry Zuev,(unknown),Paul M. Scola,Clint A. James,Edward H. Ruediger,Sokhom S. Pin,Kevin D. Burris,(unknown),Qi Gao,Dedong Wu,Lawrence K. Fung,(unknown),Kaitlin E. Browman,Matthew T. Taber,Jie Zhang	14
11	Novel 3′-deoxy analogs of the anti-HBV agent entecavir: synthesis of enantiomers from a single chiral epoxide 2003 ·Tetrahedron Letters ·Edward H. Ruediger,Alain Martel,Nicholas A. Meanwell,(unknown),(unknown)	29
12	Novel quinolizidine salicylamide influenza fusion inhibitors 1999 ·Bioorganic & Medicinal Chemistry Letters ·(unknown),Edward H. Ruediger,Guangxiang Luo,Christopher Cianci,(unknown),Laurence Tiley,Ashok K. Trehan,Ivo Monković,Bradley C. Pearce,Alain Martel,Mark Krystal,Nicholas A. Meanwell	14
13	Evaluation of cerebral pharmacokinetics of the novel antidepressant drug, BMS-181101, by positron emission tomography. 1996 ·Journal of Pharmacology and Experimental Therapeutics ·Bradley Christian,Eli Livni,John W. Babich,Nathaniel M. Alpert,Douglas D. Dischino,Edward H. Ruediger,Daniel E. Salazar,Neville F. Ford,Alan J. Fischman	21
14	Synthesis and antibacterial activity of some novel 6-methyl- and 6-propenyl-substituted carbapenems 1992 ·Journal of Medicinal Chemistry ·Harold Mastalerz,(unknown),Edward H. Ruediger,J Fung-Tomc	12
15	Synthesis and biological activity of the putative metabolites of the atypical antipsychotic agent tiospirone 1991 ·Journal of Medicinal Chemistry ·(unknown),Edward H. Ruediger,James S. New,(unknown),Timothy A. Shepherd,David W. Smith,Joseph P. Yevich	28
16	Novel conversion of a 3-(1-hydroxyethyl)azetidinone to a 3-(hydroxymethyl)azetidinone: a synthesis of 6-(hydroxymethyl)-1.beta.-methylcarbapenem 1991 ·The Journal of Organic Chemistry ·Edward H. Ruediger,(unknown)	6
17	Synthesis of functionalized bicyclo[3.2.1]octa-2,6-dienes by thermal rearrangement of substituted 6-exo-(1-alkenyl)bicyclo[3.1.0]hex-2-ene systems 1987 ·Canadian Journal of Chemistry ·Edward Piers,(unknown),Edward H. Ruediger	28
18	Preparation and thermal rearrangement of trans-3-[1-methyl-2-(2-methyl-1-propenyl)cyclopropyl]-2-cyclohexen-1-one. A synthesis of (±)-[β-himachalene 1983 ·Canadian Journal of Chemistry ·Edward Piers,Edward H. Ruediger	6
19	Reactions of 1,5-dichloroanthraquinone with nucleophiles 1980 ·The Journal of Organic Chemistry ·Edward H. Ruediger,(unknown),Sham S. Gandhi,(unknown),Martin S. Gibson	13
20	Thermal rearrangement of 1-(carbomethoxy)-6-exo-(1-alkenyl)bicyclo[3.1.0]hex-2-ene systems. A convenient synthesis of functionalized bicyclo[3.2.1]octa-2,6-dienes 1980 ·The Journal of Organic Chemistry ·Edward Piers,Edward H. Ruediger	8

About Edward H. Ruediger

Edward H. Ruediger is a scholar working on Toxicology, Virology and Organic Chemistry, having authored 26 papers that have together received 383 indexed citations. Recurring topics across this work include Bioactive Compounds and Antitumor Agents (4 papers), HIV/AIDS drug development and treatment (4 papers) and HIV Research and Treatment (3 papers). The work is most often cited by research in Organic Chemistry (193 citations), Hepatology (47 citations) and Toxicology (15 citations). Edward H. Ruediger has collaborated with scholars based in United States, Canada and Germany. Frequent co-authors include Edward Piers, Alain Martel, Nicholas A. Meanwell, Sham S. Gandhi, Martin S. Gibson, Makonen Belema, Dolatrai M. Vyas, David W. Smith, James S. New and Joseph P. Yevich. Their work appears in journals such as Journal of Molecular Biology, Journal of Medicinal Chemistry and Journal of Pharmacology and Experimental Therapeutics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact